Scarica l'app Stockscreener
36.22
3.00%
1.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Harrow Inc Borsa (HROW) Ultime notizie
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth - Bitget
Harrow Announces $50 Million Senior Unsecured Notes Offering Due 2030 to Accelerate Growth and Product Development 12 - Minichart
How Investors May Respond To Harrow (HROW) Issuing US$50M In 8.625% Senior Notes For Growth - simplywall.st
Harrow announces $50M add-on senior notes offering - MSN
Fundamentals Check: Is Harrow Inc attractive for institutional investorsNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - AOL.com
Harrow prices $50M senior unsecured notes due 2030 at 8.625% - MSN
Harrow Health Prices $50 Million Senior Notes Offering - TipRanks
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 - The Manila Times
Harrow (NASDAQ: HROW) adds $50M to 8.625% 2030 senior notes - Stock Titan
Harrow Announces $50 Million Add-On Offering of 8.625% Senior Unsecured Notes Due 2030 to Support Growth - Minichart
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - The Motley Fool
Harrow to Issue Additional $50 Million Debt Offering - marketscreener.com
Harrow Health Announces $50 Million Senior Notes Offering - TipRanks
Harrow launches $50.0M add-on 8.625% senior notes due 2030 for growth initiatives - TradingView
Harrow (NASDAQ: HROW) plans $50M add-on 8.625% 2030 note issue - Stock Titan
HC Wainwright Issues Positive Outlook for Harrow Earnings - Defense World
MongoDB, Surgery Partners, Harrow and other big stocks moving lower in Tuesday's pre-market session - MSN
EnerQuest Technologies Solutions Inc.’s Harrow facility undergoes $15.8M expansion - constructconnect.com
Harrow Health Inc stock faces valuation scrutiny amid eye care expansion push - AD HOC NEWS
HROW Stock Price, Quote & Chart | HARROW INC (NASDAQ:HROW) - ChartMill
Harrow (NASDAQ:HROW) Receives “Buy” Rating from HC Wainwright - Defense World
HROW: Analyst HC Wainwright & Co. Reiterates 'Buy' with $70 Targ - GuruFocus
Harrow's (HROW) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Harrow (HROW) to Release Quarterly Earnings on Thursday - MarketBeat
Nomura Downgrades Harrow Health, Inc. (HROW) to Neutral March 18, 2026 - Meyka
Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting - Bitget
Harrow outlines $350M–$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum - MSN
HROW: BTIG Reiterates Buy Rating with $63 Price Target | HROW St - GuruFocus
Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research - MarketBeat
Penn Capital Management Company LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
EnerQuest expansion in Essex County to bring jobs, shift production from U.S. - CBC
Harrow Emerging As Dominant Operator In U.S. Ophthalmic Market (NASDAQ:HROW) - Seeking Alpha
Cantor Fitzgerald Initiates Coverage of Harrow (HROW) with Overweight Recommendation - MSN
EnerQuest in Harrow gets support for re-shoring manufacturing - Sarnia News Today
307,337 Shares in Harrow, Inc. $HROW Bought by Luxor Capital Group LP - MarketBeat
Harrow: why this fast-growing eye-care pharma stock is worth a look - Finimize
Braidwell LP Decreases Stock Position in Harrow, Inc. $HROW - MarketBeat
Assessing Harrow (HROW) Valuation After Strong Revenue Growth And TRIESENCE Phase 3 Progress - Sahm
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why Harrow (HROW) Is Down 6.5% After Raising 2026 Guidance And Advancing TRIESENCE To Phase 3 - simplywall.st
Daniel Kaufman holds 1.878M Harrow shares (HROW) — 5.04% reported - Stock Titan
Harrow Health Projects Robust Growth After Strong 2025 - The Globe and Mail
Harrow Health at Leerink Global Healthcare Conference: Strategic Growth Focus - Investing.com
Harrow (HROW) Q4 2025 Earnings Call Transcript - AOL.com
HROW: Record growth and expanding ophthalmic portfolio drive optimism for future launches - TradingView
Harrow (NASDAQ: HROW) furnishes March 2026 corporate investor presentation - Stock Titan
Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Investing.com Canada
Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
HARROW INCHROW 8 5/8 04/30/26 (HROWL) Earnings History & Surprises - ChartMill
Is Harrow Inc. stock a top pick in earnings seasonTrade Performance Summary & Safe Entry Point Alerts - Naître et grandir
Harrow, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HROW) 2026-03-06 - Seeking Alpha
Has The Recent Slide In Harrow (HROW) Opened A Valuation Opportunity For Investors - simplywall.st
HC Wainwright Issues Negative Forecast for Harrow Earnings - MarketBeat
3.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):